On­coSec shares turn hot as mi­cro­cap re­ports promis­ing PhII da­ta for an I/O one-two punch

Shares of tiny San Diego-based On­coSec Med­ical ig­nit­ed Wednes­day morn­ing when the mi­cro­cap biotech re­port­ed that its lead drug pro­duced promis­ing Phase II melanoma da­ta …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER